General Information of Drug (ID: DMGN5QD)

Drug Name
protirelin Drug Info
Synonyms 24305-27-9; Hirtonin; TRH-SR, Takeda; protirelin
Indication
Disease Entry ICD 11 Status REF
Central nervous system disease 8A04-8D87 Approved [1]
Therapeutic Class
Neurology Agents
Cross-matching ID
PubChem CID
638678
ChEBI ID
CHEBI:35940
CAS Number
CAS 24305-27-9
TTD Drug ID
DMGN5QD
INTEDE Drug ID
DR2128

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
DME
Drug Status:
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
AZETIRELIN DMLY9F1 Pain MG30-MG3Z Phase 3 [4]
MONTIRELIN TETRAHYDRATE DM31OGZ Pain MG30-MG3Z Discontinued in Preregistration [5]
Posatirelin DML6EWH Neurodegenerative disorder 8A20-8A23 Discontinued in Phase 3 [6]
JTP-2942 DM29C6S Cognitive impairment 6D71 Discontinued in Phase 2 [7]
MK-771 DM4YQV0 Discovery agent N.A. Investigative [8]
CORYMBONE B DM463S2 Discovery agent N.A. Investigative [9]
C4X-101 DM5971G Endocrine disease 5B3Z Investigative [10]
MeTRH DMGH8WV Discovery agent N.A. Investigative [11]
⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Thyrotropin-releasing hormone receptor (TRHR) TT4J8MF TRFR_HUMAN Modulator [2]

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Pyrrolidone-carboxylate peptidase (PGPI) Main DME DEVDR46 PGPI_HUMAN Substrate [3]

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Company report (takeda)
3 Marginal involvement of pyroglutamyl aminopeptidase I in metabolism of thyrotropin-releasing hormone in rat brain. Biol Pharm Bull. 2004 Aug;27(8):1197-201.
4 Intestinal absorption of azetirelin, a new thyrotropin-releasing hormone (TRH) analogue. II. In situ and in vitro absorption characteristics of azetirelin from the rat intestine. Biol Pharm Bull. 1995 Jul;18(7):976-9.
5 Montirelin hydrate (NS-3), a TRH analog, improved the disturbance of consciousness caused by head concussion and pentobarbital in mice. Nihon Yakurigaku Zasshi. 1996 May;107(5):237-45.
6 TRH analogs at Gedeon Richter Ltd.: highlights of experimental and clinical efficacy of posatirelin. Acta Pharm Hung. 2002;72(1):62-8.
7 Effect of JTP-2942, a novel thyrotropin-releasing hormone analogue, on pentobarbital-induced anesthesia in rats. Eur J Pharmacol. 1995 Mar 24;276(1-2):177-82.
8 TRH analog MK-771 reverses neurochemical and learning deficits in medial septal-lesioned rats. Peptides. 1989 Jan-Feb;10(1):121-4.
9 Corymbones A and B, phloroglucinols with thyrotropin releasing hormone receptor 2 binding affinity from the flowers of Corymbia peltata. J Nat Prod. 2008 May;71(5):881-3.
10 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 363).
11 Thyrotropin-releasing hormone receptor type 1 (TRH-R1), not TRH-R2, primarily mediates taltirelin actions in the CNS of mice. Neuropsychopharmacology. 2013 May;38(6):950-6.